PNC FINANCIAL SERVICES GROUP, INC. - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$851,000
+4.0%
45,7220.0%0.00%0.0%
Q1 2021$818,000
+16.4%
45,7220.0%0.00%0.0%
Q4 2020$703,000
+38.9%
45,7220.0%0.00%0.0%
Q3 2020$506,000
-11.7%
45,7220.0%0.00%0.0%
Q2 2020$573,000
+10.6%
45,7220.0%0.00%0.0%
Q1 2020$518,000
-13.5%
45,7220.0%0.00%0.0%
Q4 2019$599,000
+45.4%
45,7220.0%0.00%
Q3 2019$412,000
-8.6%
45,7220.0%0.00%
Q2 2019$451,000
+279.0%
45,722
+290.8%
0.00%
Q1 2019$119,00011,7000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,594,932$48,518,00010.26%
GREAT POINT PARTNERS LLC 1,104,334$33,594,0008.06%
ACUTA CAPITAL PARTNERS, LLC 272,500$8,289,0004.62%
DAFNA Capital Management LLC 438,623$13,343,0003.64%
Parkman Healthcare Partners LLC 294,559$8,960,0003.30%
Avoro Capital Advisors LLC 4,900,000$149,058,0002.94%
Nan Fung Group Holdings Ltd 114,380$3,479,0002.39%
BVF INC/IL 1,597,966$48,610,0002.35%
SILVERARC CAPITAL MANAGEMENT, LLC 232,630$7,077,0002.18%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,391,038$133,575,0002.16%
View complete list of XENON PHARMACEUTICALS INC shareholders